StockVS

Blue Water Acquisition Corp. III (BLUWW) Stock Analysis

Blue Water Acquisition Corp. III

$0.55

+$0.10 (+21.45%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Blue Water Acquisition Corp. III is a special purpose acquisition company dedicated to effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the biotechnology, healthcare and technology sectors. The company operates within a specialized corporate vehicle sector where entities are formed specifically to identify and acquire private targets, distinguishing it from standard operating companies by its primary focus on future business combinations rather than current commercial operations. Specific details regarding the company's scale, including its market capitalization, annual revenue, and employee count, are currently unavailable in the public records provided for this specific entity. This lack of available scale data indicates that the company exists primarily as a shell entity awaiting a target acquisition, a status common for SPACs that have not yet completed their initial public offering merger. The absence of defined revenue and employee metrics suggests that the company's value proposition at this stage is derived entirely from its trust structure and potential access to public markets rather than established operational performance or market share.

Financial Health

The reported net income for the trailing twelve months stands at $-291,246, while revenue and EBITDA figures are listed as not available or zero, revealing a cost structure typical of a SPAC prior to merger where operating expenses are incurred without corresponding revenue generation. Free cash flow is not available, which implies that the company does not generate cash from operations but instead relies on the initial IPO proceeds and trust account assets to fund its administrative activities and search for a target. All three margin metrics—gross margin, operating margin, and profit margin—are reported at 0.0%, indicating that the company currently has no sales to generate a gross profit or that any costs incurred have not yet been offset by revenue streams. Total cash on hand is reported at $759,229, while debt and the debt-to-equity ratio are not available, suggesting a balance sheet that is heavily reliant on cash reserves rather than leveraged financing strategies. The current ratio is not available, making it impossible to quantify the company's short-term liquidity position relative to its current liabilities based on the provided data. Return on equity and return on assets are not available, reflecting the fact that traditional return metrics are not yet applicable to a pre-merger SPAC that has not yet established a consolidated asset base or equity structure through a completed combination.

Valuation Assessment

The trailing P/E ratio and forward P/E ratio are both not available, which is standard for companies with no earnings and implies that valuation based on earnings multiples is currently inapplicable until a target is identified and earnings begin to materialize. The price-to-book ratio is reported at -1.96, a negative figure that indicates the market capitalization is valued below the book value of the trust assets, often seen in SPACs where the market price has drifted below the net asset value per share. Price-to-sales ratio and EV/EBITDA are also not available, meaning that alternative valuation metrics cannot be used to assess the company's relative value against peers at this stage. The 52-week high and low are both recorded at $0.50, indicating that the stock has been trading at a fixed price or within a negligible range, suggesting the current price sits effectively at 0.0% below the 52-week high and 0.0% above the 52-week low. The beta value is not available, preventing a definitive assessment of the stock's price volatility relative to the broader market, though the fixed price action suggests limited movement typical of a trust stock prior to a de-SPAC transaction.

Growth & Income

Revenue growth and earnings growth rates are both not available, as the company has not yet generated revenue or earnings through its own operations, meaning there is no historical data to determine whether earnings are growing faster or slower than revenue. The company does not pay a dividend, as indicated by the not available status for both dividend yield and payout ratio, which means the company reinvests all available earnings and trust proceeds into the search for a target rather than distributing income to shareholders. Since there are no earnings to support a payout, the concept of a sustainable dividend is irrelevant for this entity, and the capital is instead preserved for the eventual business combination. The overall growth and income profile is currently defined by the potential for future value creation upon the completion of a merger rather than any existing operational growth or income generation.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Blue Water Acquisition Corp. III

Blue Water Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to target businesses in the artificial intelligence, biotechnology, healthcare, and technology sectors. Blue Water Acquisition Corp. III was incorporated in 2024 and is based in Mountainside, New Jersey.

Visit website →

Key Statistics

Market Cap
N/A
P/E Ratio
N/A
52-Week High
$0.40
52-Week Low
$0.40

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States